Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2021 August;112(4) > Minerva Medica 2021 August;112(4):500-5

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

REVIEW   

Minerva Medica 2021 August;112(4):500-5

DOI: 10.23736/S0026-4806.20.06660-4

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Trimethoprim-associated electrolyte and acid-base abnormalities

Erica MEMOLI 1, 2, Pietro B. FARÉ 3, 4, Pietro CAMOZZI 2, 5, Giacomo D. SIMONETTI 1, 2, 6, Mario G. BIANCHETTI 6, Sebastiano A. LAVA 7, 8 , Gregorio P. MILANI 1, 2, 9, 10

1 Pediatric Institute of Southern Switzerland, San Giovanni Hospital, Bellinzona, Switzerland; 2 Ente Ospedaliero Cantonale, Bellinzona, Switzerland; 3 Department of Internal Medicine, La Carità Hospital, Locarno, Switzerland; 4 Ente Ospedaliero Cantonale, Locarno, Switzerland; 5 Department of Internal Medicine, San Giovanni Hospital, Bellinzona, Switzerland; 6 Università della Svizzera Italiana (USI), Lugano, Switzerland; 7 Pediatric Cardiology Unit, Department of Pediatrics, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Lausanne, Switzerland; 8 Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Lugano, Switzerland; 9 Unit of Pediatrics, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; 10 Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy



INTRODUCTION: The antimicrobial trimethoprim is structurally related to potassium-sparing diuretics and may consequently lead to derangements in electrolyte and acid-base balance. Since no report so far analyzed the literature documenting individual cases with electrolyte and acid-base derangements induced by trimethoprim, a systematic review was carried out.
EVIDENCE ACQUISITION: We retained 53 reports documenting 68 cases (42 males and 26 females 23 to 96 years of age) of electrolyte or acid-base derangements occurring on trimethoprim for about 5 days.
EVIDENCE SYNTHESIS: One hundred five electrolyte imbalances were detected in the 68 patients: hyperkalemia (>5.0 mmol/L) in 62 (91%), hyponatremia (<135 mmol/L) in 29 (43%) and metabolic acidosis (pH<7.38 and bicarbonate <19 mmol/L) in 14 (21%) cases. Following possible predisposing factors for electrolyte and acid-base abnormalities were found in 54 (79%) patients: high-dose trimethoprim, comedication with drugs that have been associated with electrolyte and acid-base derangements, preexisting kidney disease, age ≥80 years and diabetes mellitus.
CONCLUSIONS: High-dose trimethoprim, comedicated with drugs that have been associated with electrolyte and acid-base derangements, poor kidney function, age ≥80 years and diabetes mellitus predispose to trimethoprim-associated electrolyte and acid-base abnormalities. Clinicians must recognize patients at risk, possibly avoid drug combinations that may worsen the problem and monitor the laboratory values.


KEY WORDS: Trimethoprim; Electrolytes; Systematic review

inizio pagina